These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

920 related articles for article (PubMed ID: 26339135)

  • 21. The state of the art in the management of inflammatory bowel disease.
    Hanauer SB; Present DH
    Rev Gastroenterol Disord; 2003; 3(2):81-92. PubMed ID: 12776005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First-line therapies in inflammatory bowel disease.
    Girardin M; Manz M; Manser C; Biedermann L; Wanner R; Frei P; Safroneeva E; Mottet C; Rogler G; Schoepfer AM
    Digestion; 2012; 86 Suppl 1():6-10. PubMed ID: 23051720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fc Receptor-mediated Effector Function Contributes to the Therapeutic Response of Anti-TNF Monoclonal Antibodies in a Mouse Model of Inflammatory Bowel Disease.
    McRae BL; Levin AD; Wildenberg ME; Koelink PJ; Bousquet P; Mikaelian I; Sterman AS; Bryant S; D'Haens G; Kamath R; Salfeld J; van den Brink GR
    J Crohns Colitis; 2016 Jan; 10(1):69-76. PubMed ID: 26429698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study.
    Zissimopoulos A; Vradelis S; Konialis M; Chadolias D; Bampali A; Constantinidis T; Efremidou E; Kouklakis G
    Scand J Gastroenterol; 2014 Aug; 49(8):942-9. PubMed ID: 24897131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association.
    Principi M; Cassano N; Contaldo A; Iannone A; Losurdo G; Barone M; Mastrolonardo M; Vena GA; Ierardi E; Di Leo A
    World J Gastroenterol; 2016 May; 22(20):4802-11. PubMed ID: 27239107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phytochemicals and their potential usefulness in inflammatory bowel disease.
    Somani SJ; Modi KP; Majumdar AS; Sadarani BN
    Phytother Res; 2015 Mar; 29(3):339-50. PubMed ID: 25572840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
    J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Many Inflammatory Bowel Disease Patients Are Not Immune to Measles or Pertussis.
    Cleveland NK; Rodriquez D; Wichman A; Pan I; Melmed GY; Rubin DT
    Dig Dis Sci; 2016 Oct; 61(10):2972-2976. PubMed ID: 27557706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycophenolate mofetil therapy in the management of inflammatory bowel disease--a retrospective case series and review.
    Smith MR; Cooper SC
    J Crohns Colitis; 2014 Aug; 8(8):890-7. PubMed ID: 24507162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunomodulatory Effects of Flavonoids in the Prophylaxis and Treatment of Inflammatory Bowel Diseases: A Comprehensive Review.
    Ribeiro D; Proenca C; Rocha S; Lima JLFC; Carvalho F; Fernandes E; Freitas M
    Curr Med Chem; 2018; 25(28):3374-3412. PubMed ID: 29446723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perception and clinical decisions from inflammatory bowel diseases' specialists towards positioning of new therapies in Crohn's disease and ulcerative colitis: A national web-based survey from the Brazilian IBD study group (GEDIIB).
    Romero RK; Magro DO; Queiroz NSF; Damião AOMC; Teixeira FV; Nones RB; Sassaki LY; Saad-Hossne R; Kotze PG
    Gastroenterol Hepatol; 2022; 45(7):499-506. PubMed ID: 34634427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of inflammatory bowel disease (IBD).
    Pithadia AB; Jain S
    Pharmacol Rep; 2011; 63(3):629-42. PubMed ID: 21857074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs.
    Zanoli L; Rastelli S; Inserra G; Lentini P; Valvo E; Calcagno E; Boutouyrie P; Laurent S; Castellino P
    Atherosclerosis; 2014 Jun; 234(2):346-51. PubMed ID: 24732573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent understanding of IBD pathogenesis: implications for future therapies.
    Kucharzik T; Maaser C; Lügering A; Kagnoff M; Mayer L; Targan S; Domschke W
    Inflamm Bowel Dis; 2006 Nov; 12(11):1068-83. PubMed ID: 17075348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Update on Herbal Products for the Management of Inflammatory Bowel Disease.
    Arya H; Dass R; Chopra B; Kriplani P; Deswal G; Singh Grewal A; Dhingra AK; Kumar S
    Antiinflamm Antiallergy Agents Med Chem; 2023; 22(1):1-9. PubMed ID: 37497699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New therapeutic possibilities in chronic inflammatory bowel diseases].
    Zeitz M
    Praxis (Bern 1994); 1997 Jun; 86(25-26):1071-4. PubMed ID: 9289806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic inflammatory bowel disease--pathogenic concepts and therapeutic perspectives].
    Madsen JR
    Ugeskr Laeger; 2000 Mar; 162(10):1361-6. PubMed ID: 10745672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory bowel disease: current therapeutic options.
    Domènech E
    Digestion; 2006; 73 Suppl 1():67-76. PubMed ID: 16498254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.